Axis Bank, Dalmia Bharat, Hospital stocks, TCS, Titan Co, and Tata Chemicals among top stocks to trade today

Stocks to watch: Domestic equities are expected to see a flat-to-negative start on Thursday amid subdued global cues after the Federal Reserve kept the policy rate unchanged. The Nifty futures on the Singapore Exchange (SGX) traded 23 points, or 0.12 per cent lower at 18,812.0 levels. Asian stocks braked around two-month highs on Thursday, while the dollar nursed modest losses, after the US Federal Reserve chose not to hike interest rates for the first time in 17 months, even if it opened the door to more hikes ahead, Reuters reported. The Fed left its benchmark funds rate window at 5-5.25%, and chair Jerome Powell said the U.S. central bank needed to gather more information about the economy to determine what to do next.

Here's the list of stocks that may trade actively in today's trading session

Axis Bank: Bain Capital is expected to sell a 0.75 per cent stake in the company today via a block deal. The offer price is likely in the Rs 964 - Rs 977.70 range. According to Zee Business, the deal size is estimated to be Rs 2,192 crore. 

Mahindra & Mahindra on Wednesday said it has launched its flagship SUV XUV700 in Australia. Given the strategic importance of the market, the introduction of the XUV700 in Australia marks the company's ambitious global expansion strategy, the company said. In separate news, the automobile major, as per reports, and the Hinduja group, have joined the race to acquire a key stake in MG Motor India, a wholly-owned arm of Shanghai-headquartered SAIC Motor. 

Dalmia Bharat: Jefferies has maintained a 'buy' on the stock. The target price has been revised upwards to Rs 2,490 from Rs 2,400 earlier

TCS, DCB Bank will trade ex-dividend today. 

Tata Chemicals: Morgan Stanley has downgraded the stock to Equal-weight from Overweight. It has also reduced the target price to Rs 916 from Rs 1,192 earlier. 

VMart: Amansa Holdings has bought 3.37 lakh (1.7 per cent) shares at  Rs 1,990 per share while Rowe Price Fund has reduced its stake to 0.16 per cent from 2.07 per cent, earlier. 

Hospital stocks: Jefferies has intimated coverage on the sector. The brokerage has an 'overweight' rating on Apollo Hospitals with a target price of Rs 5,950. on Fortis Healthcare, too, the brokerage has maintained an 'overweight' with a target price of Rs 335.